Cargando…

The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunotherapy in the stroma-rich pancreatic cancer model BxPC-3

α-Sulfoquinovosylacyl-1,3-propanediol (SQAP) is a semi-synthetic derivative of natural sulfoglycolipid that sensitizes tumors to external-beam radiotherapy. How SQAP affects internal radiotherapy, however, is not known. Here, we investigated the effects of SQAP for radioimmunotherapy (RIT) targeting...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takakusagi, Yoichi, Sugyo, Aya, Tsuji, Atsushi B., Sudo, Hitomi, Yasunaga, Masahiro, Matsumura, Yasuhiro, Sugawara, Fumio, Sakaguchi, Kengo, Higashi, Tatsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628266/ https://www.ncbi.nlm.nih.gov/pubmed/34839108 http://dx.doi.org/10.1016/j.tranon.2021.101285

Ejemplares similares

Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with (90)Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a BxPC-3 Xenograft Mouse Model of Refractory Pancreatic Cancer
por: Sugyo, Aya, et al.
Publicado: (2018)

Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells
por: DU, JIAN, et al.
Publicado: (2012)

Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells
por: Du, Jian, et al.
Publicado: (2023)

Comparing the Effects of Intracellular and Extracellular Magnetic Hyperthermia on the Viability of BxPC-3 Cells
por: Hannon, Gary, et al.
Publicado: (2020)

Intracellular Distributing and Interferon-γ Secretion of Human Interleukin-18 in BxPC-3 Cells
por: Yang, Jin, et al.
Publicado: (2014)

Implications of Targeted Genomic Disruption of β-Catenin in BxPC-3 Pancreatic Adenocarcinoma Cells
por: Olsen, Petter Angell, et al.
Publicado: (2014)

Oridonin alters the expression profiles of MicroRNAs in BxPC-3 human pancreatic cancer cells
por: Gui, Zhifang, et al.
Publicado: (2015)

Proton Therapy, Magnetic Nanoparticles and Hyperthermia as Combined Treatment for Pancreatic BxPC3 Tumor Cells
por: Brero, Francesca, et al.
Publicado: (2023)

Effects of Metallic and Carbon-Based Nanomaterials on Human Pancreatic Cancer Cell Lines AsPC-1 and BxPC-3
por: Wójcik, Barbara, et al.
Publicado: (2021)

Enhanced tumor targeting of cRGD peptide-conjugated albumin nanoparticles in the BxPC-3 cell line
por: Yu, Xinzhe, et al.
Publicado: (2016)

Expression profiling of wild type and β-catenin gene disrupted human BxPC-3 pancreatic adenocarcinoma cells
por: Olsen, Petter Angell, et al.
Publicado: (2015)

Comparative analysis of Notch1 and Notch2 binding sites in the genome of BxPC3 pancreatic cancer cells
por: Liu, Hao, et al.
Publicado: (2017)

Cytotoxic effect of Efavirenz in BxPC-3 pancreatic cancer cells is based on oxidative stress and is synergistic with ionizing radiation
por: Hecht, Markus, et al.
Publicado: (2018)

Silencing NEDD9 by lentivirus-delivered shRNA inhibits the growth of BxPC-3 cells in vitro and in vivo
por: Wu, Tielong, et al.
Publicado: (2019)

Novel anticancer agent, SQAP, binds to focal adhesion kinase and modulates its activity
por: Izaguirre-Carbonell, Jesus, et al.
Publicado: (2015)

Phenolic alkaloids from Menispermum dauricum inhibits BxPC-3 pancreatic cancer cells by blocking of Hedgehog signaling pathway
por: Zhou, Zhong-guang, et al.
Publicado: (2015)

Inhibitory Effect of the HASPIN Inhibitor CHR-6494 on BxPC-3-Luc, A Luciferase-Expressing Pancreatic Cancer Cell Line
por: Tanaka, Hiromitsu, et al.
Publicado: (2022)

MS-5, a Naphthalene Derivative, Induces Apoptosis in Human Pancreatic Cancer BxPC-3 Cells by Modulating Reactive Oxygen Species
por: Giri, Suman, et al.
Publicado: (2023)

Therapeutic efficacy evaluation of radioimmunotherapy with (90)Y‐labeled anti‐podoplanin antibody NZ‐12 for mesothelioma
por: Sudo, Hitomi, et al.
Publicado: (2019)

Preclinical Evaluation of Podoplanin-Targeted Alpha-Radioimmunotherapy with the Novel Antibody NZ-16 for Malignant Mesothelioma
por: Sudo, Hitomi, et al.
Publicado: (2021)

BxPC3 pancreatic cancer cells express a truncated Smad4 protein upon PI3K and mTOR inhibition
por: LEGENDRE, ONICA, et al.
Publicado: (2014)

BxPC-3-Derived Small Extracellular Vesicles Induce FOXP3+ Treg through ATM-AMPK-Sirtuins-Mediated FOXOs Nuclear Translocations
por: Shen, Tao, et al.
Publicado: (2020)

Salidroside ameliorated hypoxia‐induced tumorigenesis of BxPC‐3 cells via downregulating hypoxia‐inducible factor (HIF)‐1α and LOXL2
por: Chen, Xiaoping, et al.
Publicado: (2019)

Dickkopf-related protein 3 alters aerobic glycolysis in pancreatic cancer BxPC-3 cells, promoting CD4(+) T-cell activation and function
por: Guo, Qingqu, et al.
Publicado: (2021)

Biosynthesis and biological function of sulfoglycolipids
por: HONKE, Koichi
Publicado: (2013)

Expression of Selected miRNAs in Normal and Cancer-Associated Fibroblasts and in BxPc3 and MIA PaCa-2 Cell Lines of Pancreatic Ductal Adenocarcinoma
por: Mandys, Václav, et al.
Publicado: (2023)

FZD10‐targeted α‐radioimmunotherapy with (225)Ac‐labeled OTSA101 achieves complete remission in a synovial sarcoma model
por: Sudo, Hitomi, et al.
Publicado: (2021)

Dihomo-γ-linolenic acid inhibits growth of xenograft tumors in mice bearing human pancreatic cancer cells (BxPC-3) transfected with delta-5-desaturase shRNA
por: Yang, Xiaoyu, et al.
Publicado: (2018)

Combined treatment of pancreatic cancer xenograft with (90)Y-ITGA6B4-mediated radioimmunotherapy and PI3K/mTOR inhibitor
por: Aung, Winn, et al.
Publicado: (2017)

Response gene to complement-32 enhances metastatic phenotype by mediating transforming growth factor beta-induced epithelial-mesenchymal transition in human pancreatic cancer cell line BxPC-3
por: Zhu, Liang, et al.
Publicado: (2012)

ASF-4-1 fibroblast-rich culture increases chemoresistance and mTOR expression of pancreatic cancer BxPC-3 cells at the invasive front in vitro, and promotes tumor growth and invasion in vivo
por: FUJIWARA, MASAYA, et al.
Publicado: (2016)

Evaluation of Efficacy of Radioimmunotherapy with (90)Y-Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models
por: Sugyo, Aya, et al.
Publicado: (2015)

Radioimmunotherapy of pancreatic cancer xenografts in nude mice using (90)Y-labeled anti-α(6)β(4) integrin antibody
por: Aung, Winn, et al.
Publicado: (2016)

Therapeutic Efficacy of C-Kit-Targeted Radioimmunotherapy Using 90Y-Labeled Anti-C-Kit Antibodies in a Mouse Model of Small Cell Lung Cancer
por: Yoshida, Chisato, et al.
Publicado: (2013)

Dynamic Remodeling of the Host Cell Membrane by Virulent Mycobacterial Sulfoglycolipid-1
por: Mishra, Manjari, et al.
Publicado: (2019)

Chemical Synthesis of Marine-Derived Sulfoglycolipids, a New Class of Molecular Adjuvants
por: Manzo, Emiliano, et al.
Publicado: (2017)

The Outcome and CT Findings of Low-Dose Intensity Modulated Radiation Therapy with SQAP in a Cat with Thymoma
por: Kutara, Kenji, et al.
Publicado: (2020)

A new marine-derived sulfoglycolipid triggers dendritic cell activation and immune adjuvant response
por: Manzo, Emiliano, et al.
Publicado: (2017)

Proof of Concept Study for Increasing Tenascin-C-Targeted Drug Delivery to Tumors Previously Subjected to Therapy: X-Irradiation Increases Tumor Uptake
por: Sugyo, Aya, et al.
Publicado: (2020)

A Screening of a Library of T7 Phage-Displayed Peptide Identifies E2F-4 as an Etoposide-Binding Protein
por: Takami, Mihoko, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_joijhtcop1spqugctpn33dovo1